IMMUNOTHERAPY IN ONCOLOGICAL DISEASES: CLINICAL OUTCOMES AND PROSPECTS
Abstract
Immunotherapy has emerged as a revolutionary approach in the treatment of oncological diseases, offering new hope for patients with various types of cancer. This review focuses on the clinical outcomes of current immunotherapeutic strategies, including immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines. The effectiveness, limitations, and potential side effects of these therapies are analyzed. Additionally, recent advancements and future prospects of immunotherapy in oncology are discussed, emphasizing personalized treatment approaches and combination therapies. Immunotherapy represents a promising frontier in cancer management, with the potential to improve survival rates and quality of life for patients worldwide.
References
1. Esfahani, K., Roudaia, L., Buhlaiga, N., Del Rincon, S. V., Papneja, N., & Miller, W. H. (2020). A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future. Curr. Oncol., 27(s2), 87 97. MDPI
2. Sekine, I. (2020). Editorial for review series of Immunotherapy. Jpn. J. Clin. Oncol. 50(10), 1089 1096. OUP Academic
3. Mc Neil, V., & Lee, S. W. (2025). Advancing Cancer Treatment: A Review of Immune Checkpoint Inhibitors and Combination Strategies. Cancers, 17(9), 1408. MDPI
4. Connell, M. (2024). Immunotherapy: Revolutionizing the treatment landscape in modern medicine. J. Med. Oncol. Ther., 9(5), 230. Allied Academies
5. Ling, S. P., Ming, L. C., Dhaliwal, J. S., Gupta, M., Ardianto, C., Goh, K. W., … Shafqat, N. (2022). Role of Immunotherapy in the Treatment of Cancer: A Systematic Review. Cancers, 14(21), 5205. PMC
6. Alturki, N. A. (2023). Review of the Immune Checkpoint Inhibitors in the Context of Cancer Treatment. J. Clin. Med., 12(13), 4301. MDPI
7. Liu, Y., Chen, J., Xu, Y., & Sun, Q. (2022). Novel insight into the role of immunotherapy in gastrointestinal cancer (Review). Mol. Clin. Oncol. https://doi.org/10.3892/mco.2022.2590. Spandidos Publications
8. Verma, A., Dhenge, S., Yadav, P., … Divya, D. (2024). The impact of immunotherapy on cancer treatment outcomes: Mechanisms, efficacy, and future directions. Oncol. Radiother., 18(9), 001 006. Онкология и радиотерапия
9. Knetki Wróblewska, M., Chmielewska, I., Wojas Krawczyk, K., & Krzakowski, M. (2024). Rechallenge of immunotherapy in non small cell lung cancer patients — navigating indications and evolving perspectives. Oncol. Clin. Pract., 20(6), 428 437. Виамедика журналы
10. “Approaches and challenges in cancer immunotherapy pathways.” (2024). World J. Clin. Oncol., 15(3), 378 … Wjgnet
11. Peshin, S., Modi, S., & Singh, S. (2024). Advancements in Cancer Immunotherapy: A Comprehensive Review of Immune Checkpoint Inhibitors with a Focus on Pembrolizumab and Emerging Strategies. Med. Clin. Case Rep. J., 2(3), 430 434. URF Journals
12. Antonarelli, G., Corti, C., Tarantino, P., … Mittendorf, E. A., Disis, M. L., Curigliano, G. (2021). Therapeutic cancer vaccines revamping: technology advancements and pitfalls. Ann. Oncol., 32(12), 1537 1551. Cancer Vaccine Institute
13. Nukala, U., Messan, M. R., Yogurtcu, O. N., … (2021). A Systematic Review of the Efforts and Hindrances of Modeling and Simulation of CAR T cell Therapy. arXiv. arXiv
14. Brown, A. J., Snapkov, I., Akbar, R., Pavlović, M., Sandve, G. K., Greiff, V. (2019). Augmenting adaptive immunity: progress and challenges in the quantitative engineering and analysis of adaptive immune receptor repertoires. arXiv. arXiv
15. Brennan, M., Krause, A. L., Villar Sepúlveda, E., Prior, C. B. (2025). Pattern Formation as a Resilience Mechanism in Cancer Immunotherapy. arXiv. arXiv
